Physician

Antonio Herlander Fontelonga

According to 2025 Medicare claims, Antonio Fontelonga (NPI: 1437164100) practices hematology/oncology in the Yuma, AZ market, with the plurality of this provider's patient population coming from Yuma, AZ. This provider's primary affiliated billing organization is GORDON GRADO, M.D., INC (NPI: 1952481152; TIN: 860927588) and primary practice location at 85251-6902. Fontelonga is affiliated with the Innovation Care Partners MSSP (ACO ID: A2029), participating under the MSSP model.

Fontelonga's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 197 traditional Medicare patients, billed 48,920 HCPCS/CPT codes, and received $1,208,912 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 455 prescription claims across 97 beneficiaries totaling $1,195,821 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 22 claims. Open Payments data shows 62 records totaling $1,446. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $10,283 to $1,208,912. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $733,651 and ending at $1,195,821. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	70	145	$10,283
2016	54	91	$5,324
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	230	578	$35,245
2020	253	791	$47,455
2021	124	215	$13,864
2022	N/R	N/R	N/R
2023	210	61,458	$1,082,257
2024	197	48,920	$1,208,912

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	172	688	$733,651
2016	158	743	$1,060,627
2017	126	788	$1,457,782
2018	129	749	$1,408,690
2019	89	260	$1,011,278
2020	46	137	$1,450,275
2021	20	54	$363,949
2022	N/R	N/R	N/R
2023	76	316	$793,702
2024	97	455	$1,195,821

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	37	$30,441
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	14	$2,810
2020	N/R	30	$2,169
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	22	$287

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	40	40	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	160	438	$87
96523	Irrigation of implanted venous access drug delivery device	22	78	$14
96372	Injection of drug or substance under skin or into muscle	23	226	$10
36415	Insertion of needle into vein for collection of blood sample	87	328	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	13	364	$211,277
Abiraterone Acetate	Abiraterone Acetate	26	780	$27,032
Exemestane	Exemestane	18	1,440	$3,067
Anastrozole	Anastrozole	88	6,570	$2,180
Letrozole	Letrozole	23	1,830	$1,250

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A5061	Ostomy pouch, drainable; with barrier attached, (1 piece), each	N	N/R	11	$263
A5120	Skin barrier, wipes or swabs, each	N	N/R	11	$24

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	62	$1,446	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Antonio Herlander Fontelonga?

Tedicare shows public-source Medicare data for Antonio Herlander Fontelonga (NPI 1437164100), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Antonio Herlander Fontelonga have ACO affiliation data?

Antonio Herlander Fontelonga is shown with ACO affiliation data for Innovation Care Partners MSSP (MSSP, ACO ID A2029).

What billing organization is linked to Antonio Herlander Fontelonga?

Antonio Herlander Fontelonga is linked to GORDON GRADO, M.D., INC (billing NPI 1952481152) in the available physician profile data.

Does Antonio Herlander Fontelonga have Open Payments data?

Antonio Herlander Fontelonga has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.